Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms

US Patent 9375485 · Granted Jun 28, 2016

Estimated economic value: $5,729,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of telomerase inhibitors for the treatment of myeloproliferative disorders a2025
Use of telomerase inhibitors for the treatment of myeloproliferative disorders a2025
SHP2 inhibitor compositions and methods for treating cancer2023
Extending time to disease progression or survival in cancer patients2014
Combination therapy of her expressing tumors2012